Researchers find depression doesn't affect memory, cognition

Contrary to popular belief, depression may not significantly affect one's memory and cognition, according to a study from researchers at the University of Miami, the University of California, Davis, Columbia University and the National Institute of Neurological Diseases and Stroke.  

According to an article published May 10 by Forbes, researchers recruited 1,111 healthy participants at an average age of 71 years old living in Manhattan, New York. Over a five-year study period, participants answered questions about possible depression symptoms, took memory and cognition tests and underwent brain MRI.

Of all participants, 22 percent showed symptoms. The researchers found no connection between depression and volume in the brain's hippocampus, which "has previously been shown to 'shrink' in depressed people", according to the article.  

“Since symptoms of depression can be treated, it may be possible that treatment may also reduce thinking and memory problems,” said study author Zeki Al Hazzouri, PhD, an assistant professor of epidemiology at the University of Miami Miller School of Medicine, according to Forbes. “With as many as 25 percent of older adults experiencing symptoms of depression, it’s important to better understand the relationship between depression and memory problems.” 

Read the full story below:

""

A recent graduate from Dominican University (IL) with a bachelor’s in journalism, Melissa joined TriMed’s Chicago team in 2017 covering all aspects of health imaging. She’s a fan of singing and playing guitar, elephants, a good cup of tea, and her golden retriever Cooper.

Around the web

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.